These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32325781)

  • 21. Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia.
    van Wijk DF; Sjouke B; Figueroa A; Emami H; van der Valk FM; MacNabb MH; Hemphill LC; Schulte DM; Koopman MG; Lobatto ME; Verberne HJ; Fayad ZA; Kastelein JJ; Mulder WJ; Hovingh GK; Tawakol A; Stroes ES
    J Am Coll Cardiol; 2014 Oct; 64(14):1418-26. PubMed ID: 25277610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of hyperlipidemia with a modified low density lipoprotein apheresis system with dextran sulfate.
    Zhao YH; Zou YG; Sun QJ; Xi D; Xing CY
    Ther Apher Dial; 2007 Aug; 11(4):249-54. PubMed ID: 17661829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women.
    Lucas EA; Wild RD; Hammond LJ; Khalil DA; Juma S; Daggy BP; Stoecker BJ; Arjmandi BH
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1527-32. PubMed ID: 11932276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective in lowering LDL, without lowering HDL cholesterol.
    Lappegård KT; Enebakk T; Thunhaug H; Hovland A
    Atherosclerosis; 2016 Aug; 251():119-123. PubMed ID: 27318831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LDL-apheresis: technical and clinical aspects.
    Bambauer R; Bambauer C; Lehmann B; Latza R; Schiel R
    ScientificWorldJournal; 2012; 2012():314283. PubMed ID: 22654591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity.
    Pokrovsky SN; Afanasieva OI; Safarova MS; Balakhonova TV; Matchin YG; Adamova IYU; Konovalov GA; Ezhov MV
    Atheroscler Suppl; 2017 Nov; 30():166-173. PubMed ID: 29096833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial.
    Bloedon LT; Balikai S; Chittams J; Cunnane SC; Berlin JA; Rader DJ; Szapary PO
    J Am Coll Nutr; 2008 Feb; 27(1):65-74. PubMed ID: 18460483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of seed from Linum usitatissimum cultivar with increased phenylpropanoid compounds and hydrolysable tannin in a high cholesterol-fed rabbit.
    Króliczewska B; Miśta D; Ziarnik A; Żuk M; Szopa J; Pecka-Kiełb E; Zawadzki W; Króliczewski J
    Lipids Health Dis; 2018 Apr; 17(1):76. PubMed ID: 29631590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of lipid reduction with DALI and MONET.
    Ramlow W; Röseler E; Heigl F; Spitthöver R; Ringel J; Schmitz G; Heinzler R; Abdul-Rahman N; Leistikow F; Himmelsbach F; Schettler V; Pham J; Kozik-Jaromin J
    Atheroscler Suppl; 2017 Nov; 30():217-224. PubMed ID: 29096841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial.
    Jenkins DJ; Kendall CW; Vidgen E; Agarwal S; Rao AV; Rosenberg RS; Diamandis EP; Novokmet R; Mehling CC; Perera T; Griffin LC; Cunnane SC
    Am J Clin Nutr; 1999 Mar; 69(3):395-402. PubMed ID: 10075322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome.
    Rahmani E; Samimi M; Ebrahimi FA; Foroozanfard F; Ahmadi S; Rahimi M; Jamilian M; Aghadavod E; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z
    Mol Cell Endocrinol; 2017 Jan; 439():247-255. PubMed ID: 27619403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial.
    Dodin S; Cunnane SC; Mâsse B; Lemay A; Jacques H; Asselin G; Tremblay-Mercier J; Marc I; Lamarche B; Légaré F; Forest JC
    Nutrition; 2008 Jan; 24(1):23-30. PubMed ID: 17981439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flaxseed reduces total and LDL cholesterol concentrations in Native American postmenopausal women.
    Patade A; Devareddy L; Lucas EA; Korlagunta K; Daggy BP; Arjmandi BH
    J Womens Health (Larchmt); 2008 Apr; 17(3):355-66. PubMed ID: 18328014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia.
    Otto C; Berster J; Otto B; Parhofer KG
    J Clin Apher; 2007; 22(6):301-5. PubMed ID: 17935245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Flaxseed Oil on Serum Lipids and Lipoproteins in Hemodialysis Patients: a Randomized Controlled Trial.
    Mirfatahi M; Tabibi H; Nasrollahi A; Hedayati M
    Iran J Kidney Dis; 2016 Nov; 10(6):405-412. PubMed ID: 27904000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the duration of hyperlipidemia on cerebral lipids, vessels and neurons in rats.
    Yang W; Shi H; Zhang J; Shen Z; Zhou G; Hu M
    Lipids Health Dis; 2017 Jan; 16(1):26. PubMed ID: 28143622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic efficiency of lipoprotein(a) reduction by low-density lipoprotein immunoapheresis.
    Banyai S; Streicher J; Strobl W; Gabriel H; Gottsauner-Wolf M; Rohac M; Weidinger F; Hörl WH; Derfler K
    Metabolism; 1998 Sep; 47(9):1058-64. PubMed ID: 9751233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of LDL-apheresis in preventing restenosis after percutaneous transluminal coronary angioplasty (PTCA): LDL-apheresis angioplasty restenosis trial (L-ART).
    Yamaguchi H; Lee YJ; Daida H; Yokoi H; Miyano H; Kanoh T; Ishiwata S; Kato K; Nishikawa H; Takatsu F
    Chem Phys Lipids; 1994 Jan; 67-68():399-403. PubMed ID: 8187240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of flaxseed supplementation on lipid profile: An updated systematic review and dose-response meta-analysis of sixty-two randomized controlled trials.
    Hadi A; Askarpour M; Salamat S; Ghaedi E; Symonds ME; Miraghajani M
    Pharmacol Res; 2020 Feb; 152():104622. PubMed ID: 31899314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LDL apheresis in clinical practice: long-term treatment of severe hyperlipidemia.
    Bambauer R; Schiel R; Latza R; Klinkmann J; Schneidewind JM
    Ther Apher; 1997 Feb; 1(1):49-54. PubMed ID: 10225781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.